Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis von Berends, Sophie E., Strik, Anne S., Löwenberg, Mark, D’Haens, Geert R., Mathôt, Ron A. A.

Volltext

Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value? von Bloem, Lourens T., Leufkens, Hubert G.M., Berends, Sophie E., Vreman, Rick A., Hollak, Carla E.M., van Weely, Sonja, de Lannoy, Larissa M., Bertens, Peter J.A., Pasmooij, Anna M.G.

Volltext

Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation von Berends, Sophie E., D'Haens, Geert R. A. M., Schaap, Tiny, Vries, Annick, Rispens, Theo, Bloem, Karien, Mathôt, Ron A. A.

Volltext

Factors Influencing Clearance of Adalimumab in Patients with Crohn's Disease: A Population Pharmacokinetic Study von Berends, Sophie E, D'Haens, Geert R, Van Selm, Juliet, Strik, Anne S, Löwenberg, Mark, Ponsioen, Cyriel, Mathot, Ron

Volltext

Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients von Berends, Sophie E., van Steeg, Tamara J., Ahsman, Maurice J., Singh, Sharat, Brandse, Johannan F., D’Haens, Geert R. A. M., Mathôt, Ron A. A.

Volltext

Tu1822 – Ifx Serum Levels At Trough Do Not Adequately Reflect Exposure in IBD Patients von Berends, Sophie E., Mathot, Ron, Strik, Anne S., de Vries, Annick, Löwenberg, Mark, D'Haens, Geert R.

Volltext

Mo1856 - Clinical Feasibility of Dried Blood Sampling for Infliximab in IBD-Patients von Berends, Sophie E., D'Haens, Geert R., Bloem, Karien, Schaap, J, de Vries, Annick, Rispens, Theo, Mathot, Ron

Volltext

Sa1915 - Factors Influencing Clearance of Adalimumab in Patients with Crohn's Disease: A Population Pharmacokinetic Study von Berends, Sophie E., D'Haens, Geert R., Van Selm, Juliet, Strik, Anne S., Löwenberg, Mark, Ponsioen, Cyriel, Mathot, Ron

Volltext

832 – Dashboard Driven Dosing of Infliximab is Superior to Conventional Treatment in Inflammatory Bowel Disease: the Precision Randomized Controlled Trial von Strik, Anne S., Berends, Sophie E., Mould, Diane R., Mathot, Ron, Ponsioen, Cyriel, van den Brande, Jan, Jansen, Jeroen M., Hoekman, Daniel R., Brandse, Johannan F., Löwenberg, Mark, D'Haens, Geert R.

Volltext

Mo1845 - Higher Serum Concentrations of Vedolizumab are Associated with Superior Endoscopic Outcomes in Crohn's Disease: Data from the Love-CD Trial von Berends, Sophie E., Löwenberg, Mark, Baert, Filip J., Mathot, Ron, Clasquin, E, Van Der Woude, Christien Janneke, Hoentjen, Frank, Bossuyt, Peter, Franchimont, Denis, Rispens, Theo, de Vries, Annick, Vermeire, Severine, D'Haens, Geert R.

Volltext

Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC study von Berends, Sophie E., Strik, Anne S., Jansen, Jeroen M., Boer, Nanne K. De, Egmond, Pleun S. Van, Johannan F. Brandse, Mathôt, Ron A., D’Haens, Geert R., Löwenberg, Mark

Volltext bestellen

Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems von Broesder, Annemarie, Berends, Julia M. E., Scheepers, Sophie M., Nguyen, Duong N., Frijlink, Henderik W., Hinrichs, Wouter L. J.

Volltext

Consumer‐providers of care for adult clients of statutory mental health services von Pitt, Veronica, Lowe, Dianne, Hill, Sophie, Prictor, Megan, Hetrick, Sarah E, Ryan, Rebecca, Berends, Lynda, Lowe, Dianne

Volltext